Loading…
Advancing Research for Chronic Pain Act of 2023
Legislative Progress
Introduced
September 26, 2023
Latest Action
September 26, 2023
Primary Sponsor
Robert P. Casey, Jr.Democratic(PA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2025 · third_quarter · Health Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).
Client expense: $1,128,989 · Firm income: Not reported
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS)
2024 · fourth_quarter · Health Issues
Issues related to treatment of chronic pain Reauthorization of the Pandemic All Hazards Preparedness Act, issues related to supply chains for medical devices H.R. 4531 SUPPORT Act Reauthorization S.2922 Advancing Research for Chronic Pain Act of 2023 New Tech Add On Payment
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Budget/Appropriations
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S.2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S. 2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Issues related to treatment of chronic pain Reauthorization of the Pandemic All Hazards Preparedness Act, issues related to supply chains for medical devices H.R. 4531 SUPPORT Act Reauthorization S.2922 Advancing Research for Chronic Pain Act of 2023 New Tech Add On Payment
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Budget/Appropriations
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S.2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S. 2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Issues related to treatment of chronic pain Reauthorization of the Pandemic All Hazards Preparedness Act, issues related to supply chains for medical devices H.R. 4531 SUPPORT Act Reauthorization S.2922 Advancing Research for Chronic Pain Act of 2023 New Tech Add On Payment
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S. 2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Budget/Appropriations
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S.2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Issues related to treatment of chronic pain Reauthorization of the Pandemic All Hazards Preparedness Act, issues related to supply chains for medical devices H.R. 4531 SUPPORT Act Reauthorization S.2922 Advancing Research for Chronic Pain Act of 2023 New Tech Add On Payment
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922 Advancing Research for Chronic Pain Act of 2023. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals to advance policies related to effective pain management. Proposals related to future pandemic preparedness. Proposals related to the advancement, testing, and detection of Traumatic Brain Injury. Proposals related to the safe manufacturing of medical devices. Proposals related to the use of diagnostic tests in CLIA-waived settings.
Client expense: $1,390,000 · Firm income: Not reported
2024 · first_quarter · Health Issues
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S. 2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Budget/Appropriations
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; S.2922 - Advancing Research for Chronic Pain Act; S.3393/H.R. 4531 - Support for Patients and Communities Reauthorization Act.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922 Advancing Research for Chronic Pain Act of 2023. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to digital health technologies and innovations. Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals to advance policies related to effective pain management. Proposals related to testing for malaria.
Client expense: $810,000 · Firm income: Not reported
2023 · fourth_quarter · Health Issues
Issues related to treatment of chronic pain Reauthorization of the Pandemic All Hazards Preparedness Act, issues related to supply chains for medical devices H.R. 4531 SUPPORT Act Reauthorization S.2922 Advancing Research for Chronic Pain Act of 2023
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Budget/Appropriations
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; Advancing Research for Chronic Pain Act, S. 2922.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; Advancing Research for Chronic Pain Act, S. 2922.
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)